The Canadian Transplant Registry (CTR) identifies transplant opportunities across Canada for heart transplant candidates who are highly sensitized to Human Lymphocyte Antigens (HLA) and/or designated as medically urgent (i.e., designated as medical status 4).
This policy describes the eligibility requirements for potential transplant recipients to participate in the Inter-provincial Sharing: Heart program. View the policy here.
Starting in November 2019, the NHLAAC committee conducted its first ABHI accredited Journal Club presentation with the goal of providing a venue for Canadian HLA professionals to continue their education, knowledge sharing, and receive ABHI CE credits.
This national organ donation and transplantation COVID-19 impact dashboard was developed in response to the COVID-19 pandemic and is intended to help the community better understand, in near real time, the impact the COVID-19 crisis has had, either directly or indirectly on organ donation and transplantation practices in Canada and by extension, what impact these changes have had on potential donors and transplant candidates.